Select Publications
Journal articles
2021, 'The DNA binding properties of 9-aminoacridine carboxamide Pt complexes', Bioorganic and Medicinal Chemistry, 40, http://dx.doi.org/10.1016/j.bmc.2021.116191
,2017, 'Analysis of Alternative Strategies for the Teaching of Difficult Threshold Concepts in Large Undergraduate Medicine and Science Classes', Medical Science Educator, 27, pp. 673 - 684, http://dx.doi.org/10.1007/s40670-017-0453-x
,2014, 'Enhanced DNA repair of bleomycin-induced 3'-phosphoglycolate termini at the transcription start sites of actively transcribed genes in human cells', Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 769, pp. 93 - 99, http://dx.doi.org/10.1016/j.mrfmmm.2014.06.006
,2014, 'Characterising the atypical 5′-CG DNA sequence specificity of 9-aminoacridine carboxamide Pt complexes', Journal of Biological Inorganic Chemistry, 19, pp. 997 - 1007, http://dx.doi.org/10.1007/s00775-014-1144-3
,2014, 'The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cells', Cellular and Molecular Life Sciences, 71, pp. 1505 - 1512, http://dx.doi.org/10.1007/s00018-013-1456-4
,2014, 'The potential of acridine carboxamide Pt complexes as anti-cancer agents: A review', Anti-Cancer Agents in Medicinal Chemistry, 14, pp. 695 - 705, http://dx.doi.org/10.2174/18715206113136660361
,2013, 'The interaction of cisplatin with a human telomeric DNA sequence containing seventeen tandem repeats', Bioorganic and Medicinal Chemistry Letters, 23, pp. 1041 - 1045, http://dx.doi.org/10.1016/j.bmcl.2012.12.021
,2012, 'Controlling the size of lipid droplets: Lipid and protein factors', Current Opinion in Cell Biology, 24, pp. 509 - 516, http://dx.doi.org/10.1016/j.ceb.2012.05.012
,2012, 'Gene expression profiling of the cancer chemotherapeutic agent, Cisplatin, compared with its ineffective isomer, Transplatin.', Journal of Computer Science and Systems Biology, 5, pp. 37, http://dx.doi.org/10.4172/0974-7230.S1.02
,2010, 'Cholesterol as an evolutionary response to living with oxygen.', Evolution, 64, pp. 2179 - 2183
,2009, 'Special relationship between sterols and oxygen: Were sterols an adaptation to aerobic life?', Free Radical Biology and Medicine, 47, pp. 880 - 889
,2008, 'The anti-tumour agent, Cisplatin, and its clinically ineffective isomer, Transplatin, produce unique gene expression profiles in human cells', Cancer Informatics, 6, pp. 315 - 355
,2002, 'The interaction of cisplatin and analogues with DNA in reconstituted chromatin', Biochimica et Biophysica Acta - Gene Structure and Expression, 1579, pp. 142 - 152, http://dx.doi.org/10.1016/S0167-4781(02)00535-3
,2002, 'Cisplatin preferentially targets the linker region of the nucleosome', Biochim Biophys ACTA, 1579, pp. 142 - 152
,Conference Papers
2009, 'The Unique Gene Expression Profile of the Anti-tumour Agent, Cisplatin, Compared with its Clinically Ineffective Isomer, Transplatin.', in Proceedings of the 2nd International Conference on Biomedical and Pharmaceutical Engineering, IEEE, Singapore, presented at 2nd International Conference on Biomedical and Pharmaceutical Engineering, Singapore, 02 December 2009 - 04 December 2009
,2002, 'Investigating the effect of cisplatin on human gene expression using cDNA microarrays', in Takayama K (ed.), School of Biotechnology and Biomolecular Sciences 1st Annual Symposium, Sydney, presented at School of Biotechnology and Biomolecular Sciences 1st Annual Symposium, Sydney, 08 November 2002
,2002, 'The Interaction of cisplatin with DNA in reconstituted chromatin', in Genome Conference 2001: 22nd Annual Conference on the Organisation and Expression of the Genome, Lorne, Victoria, pp. 44 - 44, presented at Genome Conference 2001: 22nd Annual Conference on the Organisation and Expression of the Genome, Lorne, Victoria, 17 February 2002 - 21 February 2002
,2002, 'Gene expression profiling of human tumour cells using cDNA microarrays: a model test system for anti-tumour drug development', in 2nd Australian Microarray Meeting, Sth Stradbroke Island, Australia, presented at 2nd Australian Microarray Meeting, Sth Stradbroke Island, Australia
,2002, 'The interaction of anti-tumour agents with nucleosomal core DNA in reconstituted chromatin', in ComBio Conference, Sydney, presented at ComBio Conference, Sydney
,Theses / Dissertations
2006, Investigating the mechanism of action of the chemotherapeutic agent, cisplatin: drug-DNA interactions in reconstituted chromatin and human gene expression profiling.
,